Thu. Aug 5th, 2021

Israel on Monday stated the Pfizer/BioNTech COVID-19 vaccine was still extremely efficient in preventing severe disease, while likewise reporting a decline in avoiding infections and symptomatic disease. The observation accompanied the ending of social distancing requirements and the spread of a brand-new Delta variant. The vaccine efficiency of avoiding infection and symptomatic illness was up to 64% because June 6, the Health Ministry said, Reuters reported. The bright side is the vaccine was 93% reliable in avoiding severe health problem from the coronavirus, consisting of hospitalizations. MYOCARDITIS AFTER COVID-19 VACCINATION HIGHER IN MILITARY POPULATION THAN EXPECTED, STUDY FINDS
Vials of Pfizer-BioNTech COVID-19 vaccines are ready to be injected to medical personnel at the Ichilov Hospital in Tel Aviv, Israel on Dec. 20, 2020. On Monday, the Health Ministry said the vaccines effectiveness for avoiding infections and symptomatic illness had declined but stayed high for avoiding serious illness. (AP Photo/Ariel Schalit).
The ministry did not reveal what the previous effectiveness level versus infections was prior to the decrease. Around 60% of Israels population has gotten at least one shot of the Pfizer vaccine.

spacer .


Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Wizadclick | WAC MAG 2021